BREAST CANCER SCREENING PROGRAM IN THE BASQUE COUNTRY- COSTS AND HEALTH BENEFITS ASSESSMENT THROUGH DISCRETE EVENT SIMULATION

Author(s)

Arrospide A*1;Mar J1;Comas M2;Rue M3;Larrañaga N4;Acaiturri T5, Sarriugarte G6 1Hospital Alto Deba, Mondragon, Spain, 2IMIM- Institut de Recerca Hospital del Mar, Barcelona, Spain, 3Biomedical Research Institute of Lleida (IRBLLEIDA), University of Lleida. Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Lleida, Spain, 4Basque Government, Donostia, Spain, 5Hospital de Cruces, Barakaldo, Spain, 6Direccion Territorial de Sanidad de Bizkaia, Bilbao, Spain

OBJECTIVES: In the Basque Country (Spain), mammographies have been done in biennial basis to women in their fifties and sixties since 1996. The main objective of this project was the evaluation of the impact of the Screening program in terms of costs and health in the Basque women population since 1996. METHODS: A discrete event simulation model was built to represent the natural history of breast cancer in women invited to the breast cancer screening program in the Basque Country. The disease progress was described in three main states (healthy, preclinical and clinical) in the model. We assumed all women would be diagnosed at the beginning of the clinical stage unless it had been diagnosed previously through the screening program. The data collected among the 15 years when the screening program was held allowed model’s validation. In order to compare the economic impact of these scenarios mammography and treatment costs – depending on the diseasestage at diagnosis – were included. The health impact assessment was based on quality adjusted life expectancy of cancer patients. RESULTS: Since the screening program started working, 8,925 cancers were detected among 313,475 women who attended the screening which represents the 76% of the invited ones. 60% of the diagnosed cancers were detected through the screening program. All the mammographies carried out during the evaluated years costed 46 million Euros. Each cancer detected in the screened scenario costs 29,581.06€, in the background scenario the cost was 29,639.22€. In terms of total costs the background scenario had a lower cost on average until the year 2009. CONCLUSIONS: Early detection of breast cancer improves survival prognosis and decreases treatment costs for each detected cancer. In the future, the costs of the early detection program will be balanced by the savings in treatment costs.

Conference/Value in Health Info

2013-11, ISPOR Europe 2013, The Convention Centre Dublin

Value in Health, Vol. 16, No. 7 (November 2013)

Code

PCN44

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis

Disease

Oncology, Pediatrics, Reproductive and Sexual Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×